| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 1999;15:433-437
© 1999 Elsevier Science NL
a Unit of Thoracic Surgery, University Hospital of Geneva, Geneva, Switzerland
b Division of Anesthesiology, University Hospital of Geneva, Geneva, Switzerland
Received 21 September 1998; received in revised form 21 December 1998; accepted 12 January 1999.
Corresponding author. Department of Surgery, University Hospital of Geneva, rue Micheli-du-Crest 24, 1211 Geneva 14, Switzerland. Tel.: +41-22-372-7873; fax: +41-22-372-7880.
Objective: The goal of the study was to analyze the histological and clinical trends in lung carcinoma and their influence upon the preoperative evaluation, surgical procedures and survival. Methods: We retrospectively reviewed the charts of 1079 consecutive patients who underwent surgery for primary lung carcinoma between 1977 and 1996 in our institution. Patients were divided into five equal 4-year periods according to the year of surgery (1977–1980; 1981–1984; 1985–1988; 1989–1992; 1993–1996). Results: Between 1977–1980 and 1993–1996, the incidence of squamous cell carcinoma significantly declined, whereas the incidence of adenocarcinoma and bronchioloalveolar carcinoma increased. During the same period, the proportion of squamous cell carcinoma visualized at bronchoscopy and the rate of preoperative histological diagnosis significantly decreased. An increasing proportion of lobectomy and less extended resection was associated with an increasing number of patients with stage I carcinoma. Meanwhile, the operative mortality significantly declined from 9 to 4% and the 5-year survival improved from 25 up to 40%. Conclusion: Over the last two decades, the shift in histological distribution was associated with an increasing proportion of patients with stage I disease, a lower operative mortality and a better 5-year survival.
Key Words: Lung carcinoma • Operative mortality • Survival • Time trend
This article has been cited by other articles:
|
|
 |
|
  M. K. Ferguson and W. T. Vigneswaran Changes in patient presentation and outcomes for major lung resection over three decades Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 497 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Muraoka, T. Tagawa, S. Akamine, T. Oka, T. Tsuchiya, M. Araki, T. Hayashi, and T. Nagayasu Acute interstitial pneumonia following surgery for primary lung cancer. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 657 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Myrdal, G. Gustafsson, M. Lambe, L.G. Horte, and E. Stahle Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 694 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Alexiou, D. Beggs, M. L. Rogers, L. Beggs, S. Asopa, and F. D. Salama Pneumonectomy for non-small cell lung cancer: predictors of operative mortality and survival Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 476 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. S. Breathnach, D. J. Kwiatkowski, D. M. Finkelstein, J. Godleski, D. J. Sugarbaker, B. E. Johnson, and S. Mentzer Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0042 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Perrot, M. Licker, C. Bouchardy, M. Usel, J. Robert, and A. Spiliopoulos SEX DIFFERENCES IN PRESENTATION, MANAGEMENT, AND PROGNOSIS OF PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 21 - 26. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
